argus

Unichem Laboratories Ltd.

NSE: UNICHEMLABINE351A010353,929 Cr

Timeline

Time (IST)TypeMEventSrc
26 Aug, 02:03 pmUnichem Laboratories Ltd - 506690 - Clarification sought from Unichem Laboratories Ltdbse
26 Aug, 09:18 amSignificant increase in volume has been observed in Unichem Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Unichem Laboratories Limited has submitted their response.nse
25 Aug, 06:35 pmSignificant increase in volume has been observed in Unichem Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.nse
12 Aug, 10:38 amUnichem Laboratories Limited has informed the Exchange about Copy of Newspaper Publication - Financial Results for the quarter ended June 30, 2026, published in the newspapers on August 12, 2026nse
11 Aug, 01:54 pmUnichem Laboratories Ltd - 506690 - Q1 Financial Statement Of FY 2026-2027bse
11 Aug, 01:49 pmUnichem Laboratories Ltd - 506690 - Board Meeting Outcome for Outcome Of Board Meetingbse
11 Aug, 01:48 pmUnichem Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
29 Jul, 01:11 pmUnichem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
29 Jul, 01:00 pmUnichem Laboratories Ltd - 506690 - Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015bse
28 Jul, 11:50 amUnichem Laboratories Ltd - 506690 - Board Meeting Intimation for To Inter-Alia Consider And Approve The Unaudited Financial Results (Consolidated And Standalone) For The Quarter Ended 30Th June 2026.bse
14 Jul, 02:14 pmIPCA Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
10 Jul, 09:26 pmUnichem Laboratories Ltd - 506690 - Response To Clarification Sought On Price Movementbse
10 Jul, 09:21 pmSignificant movement in price has been observed in Unichem Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Unichem Laboratories Limited has submitted their response.nse
10 Jul, 06:07 pmUnichem Laboratories Ltd - 506690 - Clarification sought from Unichem Laboratories Ltdbse
10 Jul, 05:49 pmSignificant movement in price has been observed in Unichem Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.nse
06 Jul, 12:05 pmUnichem Laboratories Limited has informed the Exchange regarding ''.nse
06 Jul, 12:00 pmUnichem Laboratories Ltd - 506690 - General Announcemnetsbse
06 Jul, 11:44 amUnichem Laboratories Ltd - 506690 - Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations, 2015bse
03 Jul, 09:26 amUnichem Laboratories Limited has informed the Exchange regarding 'BRSR report for FY 2026'.nse
03 Jul, 08:53 amUnichem Laboratories Ltd - 506690 - Reg. 34 (1) Annual Report.bse
12 Jun, 05:24 pmprocedural0BSE received a Reg. 29(2) SEBI SAST disclosure for Equity Intelligence India Pvt Ltd for Unichem Laboratories Ltd.bse
12 Jun, 10:39 amshareholding_change1Unichem Laboratories received a Regulation 29(2) SAST disclosure from Equity Intelligence India Pvt Ltd regarding a shareholding change.bse
11 Jun, 02:13 pmprocedural0Unichem Laboratories clarified that the significant increase in security volume is purely market-driven and made in compliance with Regulation 30 LODR obligations.bse
11 Jun, 12:55 pmprocedural0BSE sought clarification from Unichem Laboratories Ltd on 11 Jun 2026 regarding Movement in Volume; company reply awaited.bse
11 Jun, 10:14 amprocedural0NSE noted a significant spurt in Unichem Laboratories’ trading volume and the company submitted its response to the exchange.nse
10 Jun, 06:03 pmprocedural0NSE sought an explanation from Unichem Laboratories Limited for a significant spurt in trading volume; company response is awaited.nse
01 Jun, 02:46 pmUnichem Laboratories Limited has informed the Exchange about General Updates - Intimation of Transfer of Equity Shares to the IEPF Authority in respect of Unclaimed Dividend for the Financial Year 2018-19nse
01 Jun, 01:59 pmUnichem Laboratories Limited has informed the Exchange about Copy of Newspaper Publication - Notice for transfer of Equity Shares and Unclaimed Dividend to the Investor Education and Protection Fund (IEPF) Account.nse
27 May, 09:25 amUnichem Laboratories Ltd - 506690 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
22 May, 04:58 pmUnichem Laboratories Ltd - 506690 - Resultsbse
22 May, 04:44 pmUnichem Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
22 May, 04:42 pmUnichem Laboratories Ltd - 506690 - Board Meeting Outcome for Outcome Of Board Meetingbse
06 May, 05:31 pmUnichem Laboratories Ltd - 506690 - Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended March 31, 2026, And Audited Financial Results (Standalone And Consolidated) For The Year Ended March 31, 2026.bse
20 Apr, 05:27 pmIPCA Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
13 Apr, 03:06 pmUnichem Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
12 Apr, 06:59 pmUnichem Laboratories Limited has informed the Exchange regarding 'Product recall'.nse
12 Apr, 06:54 pmUnichem Laboratories Ltd - 506690 - Announcement Under Reg. 30 - Product Recallbse
10 Apr, 10:41 amUnichem Laboratories Limited has informed the Exchange about Credit Ratingnse
10 Apr, 10:41 amUnichem Laboratories Ltd - 506690 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
02 Apr, 06:14 pmUnichem Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
20 Mar, 04:04 pmUnichem Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.nse
20 Mar, 04:00 pmUnichem Laboratories Ltd - 506690 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
06 Feb, 04:47 pmUnichem Laboratories Limited has informed the Exchange regarding 'Received an order from Deputy Commissioner of State Tax'.nse
06 Feb, 04:42 pmUnichem Laboratories Ltd - 506690 - Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015bse
05 Feb, 04:49 pmUnichem Laboratories Ltd - 506690 - Announcement under Regulation 30 (LODR)-Change in Managementbse
05 Feb, 04:45 pmUnichem Laboratories Limited has informed the Exchange regarding Appointment of Dr. (Ms) Swati Patankar as Non- Executive Independent Director of the company w.e.f. February 05, 2026.nse
05 Feb, 03:17 pmUnichem Laboratories Ltd - 506690 - Financial Resultsbse
05 Feb, 03:13 pmUnichem Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
05 Feb, 03:11 pmUnichem Laboratories Ltd - 506690 - Board Meeting Outcome for Outcome Of The Board Meetingbse
02 Feb, 04:41 pmUnichem Laboratories Ltd - 506690 - Announce Under Regulation 30 (LODR) - USFDA Inspected The Company'S Kolhapur API Facilitybse